Energous reports record 633% revenue surge as wireless power adoption scales
Energous (NASDAQ:WATT), a leading developer of RF-based wireless power networks, announced its financial results for the fiscal year ended December 31, 2025.
Energous (NASDAQ:WATT), a leading developer of RF-based wireless power networks, announced its financial results for the fiscal year ended December 31, 2025.
Maze Therapeutics (NASDAQ:MAZE), a clinical-stage biopharmaceutical company applying genetic insights to the development of precision medicines, reported its fourth-quarter and full-year 2025 financial results on Wednesday, March 25, 2026.
Paychex (NASDAQ:PAYX), a prominent provider of integrated human capital management (HCM) solutions, announced its financial results for the third quarter ended February 28, 2026.
BeyondSpring (NASDAQ:BYSI), a clinical-stage biopharmaceutical company focused on transformative cancer therapies, today announced its financial results for the fiscal year ended December 31, 2025.
ProMIS Neurosciences (NASDAQ:PMN), a biotechnology company developing antibody therapeutics for neurodegenerative diseases, reported its full-year 2025 financial results and provided a comprehensive corporate update on March 25, 2026.
QT Imaging Holdings (NASDAQ:QTI), a medical technology company specializing in radiation-free breast health management, announced its financial results for the fourth quarter and full year ended December 31, 2025.
Kingsoft Cloud Holdings (NASDAQ:KC), an independent cloud service provider in China, announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025, on March 25, 2026.
Winnebago Industries (NYSE:WGO), a North American manufacturer of outdoor lifestyle products, announced its financial results for the second quarter of fiscal 2026 on Wednesday.
KalVista Pharmaceuticals (NASDAQ:KALV) today reported financial results for the abbreviated fiscal period ended December 31, 2025, marking the company’s formal transition from a clinical-stage developer to a commercial-stage biopharmaceutical entity.
EDAP TMS (NASDAQ:EDAP), a global leader in robotic energy-based therapies, announced record financial results for the fourth quarter and full year ended December 31, 2025.
Lockheed Martin (NYSE:LMT) and the U.S. Department of War (DoW) announced a landmark framework agreement on March 25, 2026, to dramatically accelerate the manufacturing of Precision Strike Missiles (PrSM).
Local Bounti (NYSE:LOCL), a leader in controlled environment agriculture (CEA), announced its financial results for the fourth quarter and full year ended December 31, 2025.